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Abstract 
Affinity labeling studies have identified several conserved tyrosine residues in the a subunit of the nicotinic acetylcholine receptor (aY93, aY190, 
and aY 198) as being in or near the ligand binding site. Mutagenesis tudies from several aboratories have shown that substitution of phenylalanine 
for tyrosine at these positions reduces the apparent affinity for ACh. We have examined this apparent reduction in affinity further through the use 
of multiple substitutions at each position. Substitution of either phenylalanine, tryptophan, or serine resulted in an apparent decrease in agonist 
affinity, but the degree of reduction depended on both the position and the nature of the substitution. Analysis of the effects of each substitution 
suggests that each residue interacts with the quatemary N of ACh, and that each residue may make a different type of interaction with the agonist. 
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1. Introduction 
The nicotinic acetylcholine receptor (AChR) is a 
multisubunit transmembrane glycoprotein involved in 
synaptic transmission at both the neuromuscular junc- 
tion and the central nervous system. The muscle-type 
receptor is a pentameric complex consisting of four 
homologous subunits in the stoichiometry c&J [l]. 
Although the neuronal subtypes are not as well charac- 
terized, they, too, appear to be pentameric complexes 
containing two a and three non-a or /3 subunits [2]. All 
a subunits cloned to date from muscle and neuronal 
tissue exhibit a high degree of homology, suggesting that 
they share common structural features. 
A number of elegant affinity labeling studies have 
identified three conserved tyrosines on the a subunit as 
forming at least part of the ligand-binding domain of the 
receptor; they are located at position 93 (aY93), 190 
(aY190), and 198 (aY198) (the notation used is subunit/ 
amino acid/position in the Torpedo subunit) (reviewed in 
[3,4]). Subsequent mutagenesis tudies using a subunits 
from neuronal [5], mouse muscle [6], and Torpedo elec- 
troplax [7,8] AChRs have demonstrated that replace- 
ment of these tyrosines by phenylalanine leads to an 
apparent reduction in agonist affinity, as measured by 
shifts in dose-response curves for currents elicited by 
bath application of ACh to voltage-clamped Xenopus 
oocytes expressing either wild-type or mutant AChRs. 
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In this report, we have examined the interaction of 
ACh with these three conserved tyrosines in the mouse 
muscle AChR in greater detail by making multiple sub- 
stitutions at each position and examining the functional 
consequences of each change. In all cases, replacement 
of the tyrosine by phenylalanine, tryptophan, or serine 
leads to a reduction in the apparent affinity of ACh for 
the receptor; however, the exact effect at each position 
depends upon the chemical nature of the substitution. 
2. Materials and methods 
2.1. Plasmids and site-directed mutagenesis 
Mouse muscle AChR subunit cDNAs were obtained from Dr. J.P. 
Merlie (Washington University; a subunit), N. Davidson (California 
Institute of Technology; /3 and 6 subunits), and S. Heinemann (Salk 
Institute; y subunit). The a subunit was subcloned into the pALTER-1 
vector (Promega, Madison, WI). 
Mutagenesis of the a subunit was carried out using the commercially- 
available ALTERED SITES system (Promega, Madison, WI). The 
mutagenic primers were 17-21 nucleotides long and were synthesized 
using an Applied Biosystems Model 391 oligonucleotide synthesizer. 
Mutations were confirmed by sequence analysis using the Sanger dide- 
oxy termination method (Sequenase, US Biochemicals, Cleveland, OH) 
through the entire coding region in order to verify that only the desired 
nucleotide changes were present. 
2.2. In vitro transcription and expression in Xenopus oocytes 
Plasmid DNAs were linearized with the appropriate restriction en- 
zymes and transcribed in vitro using SP6 RNA polymerase as described 
previously [9]. Oocytes were harvested from mature female Xenopus 
laevis (Xenopus One, Ann Arbor, MI) and the adhering follicle cell 
layer was removed using collagenase (Type IA, Sigma). Isolated, folli- 
cle-free oocytes were maintained in SOS (100 mM NaCl, 2 mM KCI, 
1.8 mM CaCl,, 1 mM MgCl,, 5 mM HEPES, pH 7.6) supplemented 
with 2.5 mM sodium pyruvate and 50&m] gentamicin. AChR subunit 
RNAs were mixed in a molar stoichiometry of 2 : 1: 1: 1 (a :p : y : s) and 
8-15 ng were injected into the oocyte cytoplasm. Oocytes were main- 
tained in SOS supplemented with pyruvate and gentamicin at 19°C for 
18-72 h prior to recording. 
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2.3. Electrophysiology 
Currents elicited by bath application of various concentrations of 
ACh were measured using a standard two-microelectrode voltage 
clamp (either a GeneClamp 500 (Axon Instruments, Foster City, CA) 
or an OC-725 (Warner Instruments, Hamden, CT)) at a holding poten- 
tial of -70 mV. Electrodes were filled with 3 M KC1 and had resistances 
of 0.5-3 MR. The recording chamber was continuously perfused with 
a low-Ca2+ saline (100 mM NaCI, 2 mM KCI, 0.1 mM CaCI,, 5 mM 
MgCl,, 10 mM HEPES, pH 7.6) containing 300 nM atropine to block 
any residual muscarinic ACh receptors that remained after removal of 
the follicle cells. The low Ca*’ saline was used in order to reduce 
receptor desensitization, which is enhanced by external Ca2+ [lO,l I]. 
ACh blocks AChR channels in a voltage-dependent fashion, with a 
dissociation constant on the order of 5 mM at -70 mV [12]. Such a 
block would reduce the amplitude of the macroscopic currents at high 
ACh concentrations and negative membrane potentials. At -70 mV this 
block does not become significant until the ACh concentration exceeds 
2 mM; therefore, in this study, ACh concentrations were limited to 
<lmM. 
2.4. Data analysis 
Macroscopic dose-response curves from individual oocytes were fit 
to Eqn. (la) using a Levenberg-Marquart algorithm from a commer- 
cially-available software package (Igor, Wave Metrics, Oswego, OR): 
I 
I = 1 + (Ez5;[A]) 
I and f,,, are the currents at a given ACh concentration, and the 
maximal value, respectively, ECSo is the concentration of ACh required 
to obtain half-maximal current, and n is the apparent Hill coefficient. 
Data from individual oocytes were then normalized to the value of I,,, 
determined for each oocyte, and then the normalized data from 3-7 
oocytes were fit to Eqn. (lb) to obtain final estimates of ECJo and n.: 
0 = [I + (EC,d[A])“-’ 
where 19 is the normalized current (III,,,,,). 
(lb) 
3. Results and discussion 
Replacement of one of the conserved tyrosines (aY93, 
aY 190, and aY 198) on the a subunit by phenylalanine, 
tryptophan, or serine leads to an apparent reduction in 
ACh affinity, as measured by shifts in the dose-response 
curves for ACh-elicited currents. Fig. 1 shows the effects 
of phenylalanine substitution at positions aY93 
(aY93F), aY190 (aY190F), and aY198 (aY198F). When 
compared on a &/fmol receptor basis, all mutations 
described in this report give essentially the same maxi- 
mum currents; however all three mutations lead to a shift 
in the dose response curve towards higher concentra- 
tions. Wild-type receptors have an EC5,, value for ACh 
on the order of 20 ,uM, while those for aY93F, aY 190F, 
and aY 198F are 350,8 10, and 88 ,uM, respectively. It can 
be seen that the same substitution at different positions 
decreases the apparent affinity for ACh from 4- to 40- 
fold, depending upon the position of the substitution. 
Figs. 2 and 3 compare the effects of multiple substitu- 
tions at positions aY93 (Fig. 2) and olY198 (Fig. 3). 
While replacement of tyrosine by phenylalanine, trypto- 
phan, and serine all lead to a reduction in the apparent 
affinity of ACh, the actual magnitude of the reduction 
depends on both the position and the actual substitution. 
For example, replacement of aY93 by phenylalanine 
(aY93F), tryptophan (aY93W), or serine (aY93S) all 
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Fig. 1. Dose-response curves for phenylalanine for tyrosine substitu- 
tions. Oocytes expressing wild-type or mutant AChRs were voltage- 
[AChl, PM 
clamped at -60 mV and the currents elicited by bath application of 
various concentrations of ACh were measured. Currents from individ- 
ual oocytes were normalized as described in the text. Each point repre- 
sents the mean f S.E.M. of 5-7 determinations. The smooth curves are 
described by Eqn. (lb) using parameters listed in Table I. The symbols 
used are: WT (0), c~Y93F (A), aY190F (o), and aY198F (m). 
reduce the apparent affinity by 20-30-fold. On the other 
hand, replacement of aY 198 by another aromatic amino 
acid (aY 198F and aY 198W ) has a small effect (an ap- 
proximate 5-fold decrease in affinity), while replacement 
by a non-aromatic amino acid (aY 198s) leads to a much 
larger change (30-fold decrease in affinity). 
Table 1 summarizes the results of all of the substitu- 
tions at positions aY93, aY190, and aY198. We were 
unable to detect currents elicited by ACh at concentra- 
tions up to 1 mM from oocytes expressing aY 190s recep- 
tors. However, using the binding of “‘1-a-bungarotoxin 
(a competitive antagonist) or lz51-mAb 210 (which recog- 
nizes residues 67-76 on the a subunit) to detect the pres- 
ence of receptor complexes on the oocyte surface, we 
found that aY 190s receptors were present on the oocyte 
surface at levels similar to those of the other receptors 
in this study (data not shown). Presumably, they are 
either unable to couple agonist binding to channel open- 
ing and are thus non-functional, or their apparent affin- 
ity has been reduced to such an extent that 1 mM ACh 
(the upper limit used in this study) was too low elicit 
detectable currents. 
ACh can be considered to be made up of two domains 
_ the choline moiety, which contains the quaternary N, 
and the acetyl moiety, which contains a carbonyl group. 
If ACh interacts with aY93, aY190, and aY198, then 
one or both parts of the ACh molecule could interact 
with these residues. In order to determine which part of 
the ACh molecule the tyrosines may interact with, we 
used the partial agonist phenyltrimethylammonium 
(PTMA) in which the acetyl moiety is replaced by a 
phenyl ring. In contrast to Torpedo AChRs, from which 
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Fig. 2. Dose-response curves for substitutions at aY93. Dose-response 
data were collected and analyzed as described in the legend to Fig. 1. 
Each point represents the mean f S.E.M. of 5-7 determinations. The 
symbols used are: WT (0), aY93F (A), aY93W (o), and aY93S (m). 
Note that all three substitutions have essentially the same effect. 
tions aY93 and aY 198 plotted against he EC,, value for 
ACh. Although we could detect currents elicited by 
PTMA from aY 190F and aY 190W receptors, they were 
too small to accurately determine EC&, values. The plot 
shows that each substitution has a similar effect on the 
EC,, values for both agonists. Since the only portion that 
the two agonists have in common is the quaternary N, 
this strongly suggests that if aY93 and aY198 directly 
interact with agonists, they most likely do so at the qua- 
ternary N. It must be emphasized, however, that these 
data do not prove that ACh interacts directly with the 
tyrosines under study here, but they could instead play 
an indirect role in coupling ligand binding to channel 
opening. However, the fact that in the Torpedo AChR 
changes in the affinity of the competitive antagonist cu- 
rare are similar to those of the ACh E& for aY93F, 
aY 190F, and aY 198F receptors suggests that these resi- 
dues are involved in ligand-receptor interactions [8], 
rather than coupling ligand binding to channel opening 
as we previously suggested [7]. 
we were unable to detect PTMA-evoked currents from 
mutant receptors [7], we were able to record small 
PTMA-evoked currents from mouse AChRs containing 
mutations at positions aY93, aY190, and aY198. This 
is most likely due to the fact that macroscopic currents 
recorded from mouse AChRs expressed in Xenopus 
oocytes are much larger and desensitize more slowly 
compared to their Torpedo counterparts at a given ACh 
concentration, allowing the detection of much smaller 
fractional currents. Fig. 4 shows the EC,,,‘s for PTMA- 
elicited currents from WT and the substitutions at posi- 
Tyrosine can, in principle, make two types of interac- 
tions with the quaternary N of ACh. First, if the local 
environment of a tyrosine is such that the pK, of the 
tyrosine hydroxyl is reduced from its normal value of 9.7 
to a value closer to 7.6 (the pH used in the experiments), 
a significant fraction of the tyrosine could be in the ani- 
onic tyrosinate form and make a salt bridge-type interac- 
tion with the quaternary N of ACh. While this may seem 
unlikely, the fact that aY 190 in the Torpedo AChR forms 
a covalent adduct with lophotoxin analog- 1 led Abram- 
son et al. [13] to conclude that aY 190 is an excellent 
nucleophile, which is consistent with this notion. Second, 
tyrosine (and other aromatic groups) can form a cation- 
Table 1 
Macroscopic dose-response relationships for wild type and mutant AChRs 
Receptor EC,, n ECSu ratio (mutant/WT) d(dG), kcal/mol 
WT 19.3 I!I 0.6 1.5 f 0.1 1 - 
aY93F 353.2 ?r 16.4 1.4 * 0.1 18 1.7 
aY93W 705.8 f 43.2 1.6 f 0.1 36 2.1 
aY93S 545.4 f 38.7 1.4 _+ 0.1 28 2.0 
aYl90F 812.3 f 36.0 1.6 f 0.1 42 2.2 
aYl90W 208.3 f 13.8 1.6 f 0.1 11 1.4 
aY190S ND ND ND - 
aYl98F 88.1 If: 2.9 1.5 f 0.1 4 0.8 
al98W 124.1 f 1.7 1.6 IL 0.1 6 1.0 
al98S 635.0 f 57.1 1.9 _+ 0.2 34 2.1 
Concentrations of ACh required for half-maximal current (EC,,) and the apparent Hill coefficients (n) were estimated from fits of doseeresponse 
data to Eq. (lb) as described in the text. Each value is the mean + S.E.M. of 5-7 determinations. ND, no current detected. The change in free energy 
due to the mutation, d(dG), is defined as: 
d(dG) = RTln 
EGO (mut) 
EC,, (WT) 
where EC,,(mut) and EC,,,(WT) are the EC,, values for the mutant and wild-type receptors, respectively. 
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n interaction between the unpaired z-electrons of the 
aromatic ring and the quaternary N of ACh [14]. If a 
chargecharge interaction takes place, then replacement 
of tyrosine by phenylalanine, tryptophan, or serine 
should remove this interaction, and each substitution 
should give a similar reduction in affinity. On the other 
hand, if tyrosine is involved in a cation-n interaction, 
then the serine substitution should eliminate this interac- 
tion. Phenylalanine and tryptophan are capable of mak- 
ing cation-n interactions, and thus substitution of these 
residues should either have no effect or a much smaller 
(due to less-than-optimal geometry compared to tyro- 
sine) effect than replacement by serine. 
With this logic in mind, we can make some specula- 
tions as to the types of interactions that may take place 
in the ligand binding site. In the case of the mutations 
at aY93, the fact that all three substitutions have essen- 
tially the same effect (&lG) approximately 2 kcal/mol) 
suggests that this residue makes an interaction that is 
rather specific to tyrosine, such as a salt bridge. The 
substitutions at aY198 indicate that a different type of 
interaction may take place at this position. Substitution 
by aromatic amino acids has a much smaller effect than 
replacement by serine (d(dG) approximately 1 kcaVmo1 
for the aromatic substitutions vs. 2 kcal/mol for serine). 
This is consistent with the notion that aY198 makes an 
interaction that depends upon the aromatic nature of the 
side chain such as cation-n interactions. The reduction 
in apparent affinity after substitution by phenylalanine 
or tryptophan at aY 198 may be due to a less-than-opti- 
mal geometry which could result in a weaker cation-n 
interaction. In the case of aY 190, the lack of information 
about the underlying cause of the lack of a response of 
(rY19OS mutations (i.e. non-functional or a very low 
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Fig. 3. Dose-response data for substitutions at aY198. Dose-response 
data were collected and analyzed as described in the legend to Fig. I. 
Each point represents the mean k S.E.M. of 5-7 determinations. The 
symbols used are: WT (o), aY 198F (A), aY l98W (o), and aY 198s (m). 
Note that the aromatic substitutions (aYl98F and aYl98W) have a 
smaller effect than the serine substitution. 
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Fig. 4. Relationship between EC,+ for ACh and PTMA activation. 
Dose-response data were collected using ACh and PTMA as agonists 
and the ECS,, values were determined as described in the text. Each point 
represents the mean + S.E.M. (in both x and y directions) of 5-7 deter- 
minations. The receptors are identified as follows: (a), WT; (b), aY93F; 
(c), aY93W, (d), aY93S; (e). aYl98F; (f), aYl98W; (g), aYl98S. The 
straight line is for illustrative purposes only, and has no theoretical 
significance. 
apparent affinity) limits our ability to speculate about 
the types of interactions (if any) that this residue may 
make with the agonist. 
The overall picture of the binding site that has 
emerged from this and other studies is one in which a 
number of aromatic amino acids play an important role 
in determining ligand-receptor interactions. This is simi- 
lar to the situation in acetylcholinesterase, in which anal- 
ysis of the structure at atomic resolution has shown that 
the substrate binding site is in what has been termed the 
‘aromatic gorge’ [ 151. Although our current pictures of 
the structure of the AChR are not of sufficient resolution 
to determine the arrangement of amino acid side chains 
in the ligand binding site [16], the combination of site- 
directed mutagenesis and analysis of the functional con- 
sequences of the changes does provide some insight into 
the interactions that take may place during the process 
of the transduction of ligand binding to channel opening. 
Further analyses of this type, employing a wider variety 
of ligands of defined structure, should enable us to pro- 
vide a better picture of the structure of the ligand-binding 
site. 
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